Cargando…

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study

BACKGROUND: Chronic kidney disease (CKD) eventually progresses to end-stage renal disease (ESRD). However, risk factors associated with CKD progression have not been well characterized in Japanese patients with CKD who are less affected with coronary disease than Westerners. METHODS: A large-scale,...

Descripción completa

Detalles Bibliográficos
Autores principales: Inaguma, Daijo, Imai, Enyu, Takeuchi, Ayano, Ohashi, Yasuo, Watanabe, Tsuyoshi, Nitta, Kosaku, Akizawa, Tadao, Matsuo, Seiichi, Makino, Hirofumi, Hishida, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486452/
https://www.ncbi.nlm.nih.gov/pubmed/27412450
http://dx.doi.org/10.1007/s10157-016-1309-1
_version_ 1783246251749277696
author Inaguma, Daijo
Imai, Enyu
Takeuchi, Ayano
Ohashi, Yasuo
Watanabe, Tsuyoshi
Nitta, Kosaku
Akizawa, Tadao
Matsuo, Seiichi
Makino, Hirofumi
Hishida, Akira
author_facet Inaguma, Daijo
Imai, Enyu
Takeuchi, Ayano
Ohashi, Yasuo
Watanabe, Tsuyoshi
Nitta, Kosaku
Akizawa, Tadao
Matsuo, Seiichi
Makino, Hirofumi
Hishida, Akira
author_sort Inaguma, Daijo
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD) eventually progresses to end-stage renal disease (ESRD). However, risk factors associated with CKD progression have not been well characterized in Japanese patients with CKD who are less affected with coronary disease than Westerners. METHODS: A large-scale, multicenter, prospective, cohort study was conducted in patients with CKD and under nephrology care, who met the eligibility criteria [Japanese; age 20–75 years; and estimated glomerular filtration rate (eGFR): 10–59 mL/min/1.73 m(2)]. The primary endpoint was a composite of time to a 50 % decline in eGFR from baseline or time to the initiation of renal replacement therapy (RRT). The secondary endpoints were the rate of decline in eGFR from baseline, time to a 50 % decline in eGFR from baseline, time to the initiation of RRT, and time to doubling of serum creatinine (Cre) concentration. RESULTS: 2966 patients (female, 38.9 %; age, 60. 3 ± 11.6 years) were enrolled. The incidence of the primary endpoint increased significantly (P < 0.0001) in concert with CKD stage at baseline. The multivariate Cox proportional hazards models revealed that elevated systolic blood pressure (SBP) [hazard ratio (HR) 1.203, 95 % confidence interval (CI) 1.099–1.318)] and increased albumin-to-creatinine ratio (UACR ≥ 1000 mg/g Cre; HR: 4.523; 95 % CI 3.098–6.604) at baseline were significantly associated (P < 0.0001, respectively) with the primary endpoint. CONCLUSIONS: Elevated SBP and increased UACR were risk factors that were significantly associated with CKD progression to ESRD in Japanese patients under nephrology care. UMIN clinical trial registry number: UMIN000020038. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10157-016-1309-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5486452
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-54864522017-07-17 Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study Inaguma, Daijo Imai, Enyu Takeuchi, Ayano Ohashi, Yasuo Watanabe, Tsuyoshi Nitta, Kosaku Akizawa, Tadao Matsuo, Seiichi Makino, Hirofumi Hishida, Akira Clin Exp Nephrol Original Article BACKGROUND: Chronic kidney disease (CKD) eventually progresses to end-stage renal disease (ESRD). However, risk factors associated with CKD progression have not been well characterized in Japanese patients with CKD who are less affected with coronary disease than Westerners. METHODS: A large-scale, multicenter, prospective, cohort study was conducted in patients with CKD and under nephrology care, who met the eligibility criteria [Japanese; age 20–75 years; and estimated glomerular filtration rate (eGFR): 10–59 mL/min/1.73 m(2)]. The primary endpoint was a composite of time to a 50 % decline in eGFR from baseline or time to the initiation of renal replacement therapy (RRT). The secondary endpoints were the rate of decline in eGFR from baseline, time to a 50 % decline in eGFR from baseline, time to the initiation of RRT, and time to doubling of serum creatinine (Cre) concentration. RESULTS: 2966 patients (female, 38.9 %; age, 60. 3 ± 11.6 years) were enrolled. The incidence of the primary endpoint increased significantly (P < 0.0001) in concert with CKD stage at baseline. The multivariate Cox proportional hazards models revealed that elevated systolic blood pressure (SBP) [hazard ratio (HR) 1.203, 95 % confidence interval (CI) 1.099–1.318)] and increased albumin-to-creatinine ratio (UACR ≥ 1000 mg/g Cre; HR: 4.523; 95 % CI 3.098–6.604) at baseline were significantly associated (P < 0.0001, respectively) with the primary endpoint. CONCLUSIONS: Elevated SBP and increased UACR were risk factors that were significantly associated with CKD progression to ESRD in Japanese patients under nephrology care. UMIN clinical trial registry number: UMIN000020038. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10157-016-1309-1) contains supplementary material, which is available to authorized users. Springer Japan 2016-07-13 2017 /pmc/articles/PMC5486452/ /pubmed/27412450 http://dx.doi.org/10.1007/s10157-016-1309-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Inaguma, Daijo
Imai, Enyu
Takeuchi, Ayano
Ohashi, Yasuo
Watanabe, Tsuyoshi
Nitta, Kosaku
Akizawa, Tadao
Matsuo, Seiichi
Makino, Hirofumi
Hishida, Akira
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title_full Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title_fullStr Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title_full_unstemmed Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title_short Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
title_sort risk factors for ckd progression in japanese patients: findings from the chronic kidney disease japan cohort (ckd-jac) study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486452/
https://www.ncbi.nlm.nih.gov/pubmed/27412450
http://dx.doi.org/10.1007/s10157-016-1309-1
work_keys_str_mv AT inagumadaijo riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT imaienyu riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT takeuchiayano riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT ohashiyasuo riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT watanabetsuyoshi riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT nittakosaku riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT akizawatadao riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT matsuoseiichi riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT makinohirofumi riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT hishidaakira riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy
AT riskfactorsforckdprogressioninjapanesepatientsfindingsfromthechronickidneydiseasejapancohortckdjacstudy